A 2016 Journal of Health Economics article reports that drug companies spend over 10 years and up to $2.6 billion bringing a drug to market. The cost, effort, and time required has become unsustainable. Much of these costs are a result of overly-complex multi-institutional administrative and clinical trial management issues. Hashed Health and its Life Sciences partners are working on a variety of innovative approaches to concepts including patient consent, incentives, multi-constituent study administration, trial audit, patient recruiting & retention, and outcomes data collection.